Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2026-01-14 @ 12:12 PM
Study NCT ID:
NCT00059995
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2003-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent adult Hodgkin lymphoma | View |
| None | recurrent/refractory childhood Hodgkin lymphoma | View |
| None | anaplastic large cell lymphoma | View |
| None | recurrent adult diffuse large cell lymphoma | View |
| None | recurrent childhood large cell lymphoma | View |
| None | recurrent cutaneous T-cell non-Hodgkin lymphoma | View |